Home » Topics » Regulatory » Patents

Patents
RSS

Jiangsu Hansoh Pharmaceutical patents FXR agonists

Nov. 11, 2016

Lead Discovery Center and Qurient present TAM receptor kinases and/or MET inhibitors

Nov. 10, 2016

Kainos Medicine develops Brd inhibitors

Nov. 10, 2016

Takeda Pharmaceutical describes orexin receptor antagonists

Nov. 10, 2016

ViiV Healthcare UK discloses antiviral agents

Nov. 10, 2016

Sumitomo Dainippon Pharma patents dopamine D4 receptor agonists

Nov. 10, 2016

Shionogi presents P2X7 antagonists

Nov. 9, 2016

Takeda Pharmaceutical develops SPT inhibitors

Nov. 9, 2016

Araxes Pharma describes mutant K-RAS, H-RAS or N-RAS inhibitors

Nov. 9, 2016

FORMA Therapeutics discloses mutant IDH1 inhibitors

Nov. 9, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...